Approaches to the rational design of selective melanocortin receptor antagonists

Bibliography

• Hadley ME, editor, The Melanotropic peptides, Volumes I, II and III, CRC Press, Boca Raton, FL, 1988
   Google Scholar
• Cone RD, editor, The melanocortin system. Ann NY Acad Sci 2003;994:387
   Google Scholar
• Cone RD, editor, The melanocortin receptors. Humana Press, Inc.: Totowa NJ; 2000. p. 551
   Google Scholar
• Vandry H, Eberle AN, editors, The melanotropic peptides. Ann NY Acad Sci 1993;680:687
   Google Scholar
• Kreiger DT, Ganong WF, editors, ACTH and related peptides: structure, regulation and action. Ann NY Acad Sci 1977;297:664
   Google Scholar
• Sawyer TK, Sanfilippo PJ, Hruby VJ, [Nle4, D-Phe7]-alpha-melanocyte stimulating hormone: a highly potent alpha-melanotropin with ultralong biological activity. Proc Natl Acad Sci USA 1980;77:5754-8
   PubMed Web of Science ®Google Scholar
• Al-Obeidi F, Hadley ME, Pettitt BM, Design of a new class of superpotent cyclic alpha-melanotropins based on quenched dynamic simulations. J Amer Chem Soc 1989;111:3413-16
   Web of Science ®Google Scholar
• Al-Obeidi F, de Lauro Castrucci AM, Hadley ME, Potent and prolonged acting cyclic lactam analogues of alpha-melanotropin: design based on molecular dynamics. J Med Chem 1989;32:2555-61
   PubMed Web of Science ®Google Scholar
• Hruby VJ, Lu D, Sharma SD, Cyclic lactam alpha-melanotropin analogues of Ac-Nle4-c[Asp5,D-Phe7,Lys10]alpha-MSH(4-10)-NH2 with bulky aromatic amino acids at position 7 show high antagonist potency and selectivity at specific melanocortin receptors. J Med Chem 1995;38:3454-61
   PubMed Web of Science ®Google Scholar
• Al-Obeidi F, Hruby VJ, Hadley ME, Design, synthesis and biological activities of a potent and selective alpha-melanotropin antagonist. Int J Peptide Protein Res 1990;35:228-34
   PubMedGoogle Scholar
• Medzihradszky K. The bio-organic chemistry of alpha-melanotropin. Medical Res Rev 1982;2:247-70
   PubMed Web of Science ®Google Scholar
• Seelig S, Lindley BD, Sayers G. A new approach to the structure-activity relationship for ACTH analogs using isolated adrenal cortex cells. Methods Enzymol 1975;39D:347-59
   Google Scholar
• Schwyzer R. ACTH: a short introduction review. In: Kreiger DT, Ganong WF, editors, ACTH and related peptides: structure, regulation and action. Ann NY Acad Sci 1977;297:3-26
   PubMedGoogle Scholar
• Hruby VJ. Conformational restrictions of biologically active peptides via amino acid side chain groups. Life Sci 1982;31:189-99
   PubMed Web of Science ®Google Scholar
• Hruby VJ. Design of peptide superagonists and antagonists: conformational and dynamic considerations. In: Vida JA, Gordon M, editors, Conformationally directed drug design peptides and nucleic acids as templates or targets. ACS Symposium Series No. 251, Washington, DC; 1984. p. 9-27
   Google Scholar
• Hruby VJ, Al-Obeidi F, Kazmierski WM. Emerging approaches in the molecular design of receptor selective peptide ligands: conformational, topographical and dynamic considerations. Biochemical J 1990;268:249-62
   PubMed Web of Science ®Google Scholar
• Cowell SM, Balse-Srinivasan PM, Ahn JM, Design and synthesis of peptide antagonists and inverse agonists for G-protein coupled receptors. Volume 343. In: Iyengar R, Hildebrandt JD, editors, Methods in Enzymology. Academic Press, San Diego, CA; 2002. p. 49-72
   Google Scholar
• Hruby VJ. Designing peptide receptor agonists and antagonists. Nat Rev Drug Discov 2002;1:847-58
   PubMed Web of Science ®Google Scholar
• Hruby VJ, Wilkes BC, Cody WL, Melanotropins: structural, conformational, and biological considerations in the development of superpotent and superprolonged analogs. Peptide Protein Rev 1984;3:1-64
   Google Scholar
• Hruby VJ, Li G, Haskell-Luevano C, Design of peptides, proteins, and peptidomimetics in chi space. Biopolymers 1997;43:219-66
   PubMed Web of Science ®Google Scholar
• Doedens L, Opperer F, Cai M, Multiple N-Methylation of MT-II backbone amide bonds leads to melanocortin receptor subtype hMC1R selectivity: pharmacological and conformational studies. J Amer Chem Soc 2010;132:8115-28
   PubMed Web of Science ®Google Scholar
• Golz S, Bruggermeier U, Geerts A. Diagnostics, drug screening and therapeutics for diseases associated with human melanocortin 1 receptor ( MC1R ). US20070037226; 2007
   Google Scholar
• Xia Y, Wikberg J, Chhajlani V. Expression of melanocortin 1 receptors in periaqueductal gray matter. Neuroreport 1995;6:2193-6
   PubMed Web of Science ®Google Scholar
• Mogil JS, Wilson SG, Chesler EJ, The melanocortin-1 receptor gene mediates female-specific mechanisms of analgesia in mice and humans. Proc Natl Acad Sci USA 2003;100:4867-72
   PubMed Web of Science ®Google Scholar
• Liem E, Joinen T, Tsueda K, Increased sensitivity to thermal pain and reduced subcutaneous lidocaine efficacy in redheads. Anesthesiology 2005;102:509-14
   PubMed Web of Science ®Google Scholar
• Han G, Quillan JM, Carlson K, Design of novel chimeric melanotropin-deltorphin analogues. Discovery of the first potent human melanocortin 1 receptor antagonist. J Med Chem 2003;46:810-19
   PubMed Web of Science ®Google Scholar
• Mayorov AV, Han SY, Cai M, Effects of macrocycle size and rigidity on melanocortin receptor-1 and -5 selectivity in cyclic lactam alpha-melanocyte-stimulating hormone analogs. Chem Biol Drug Design 2006;67:329-35
   PubMed Web of Science ®Google Scholar
• Juni A, Cai M, Stankova M, Sex-specific mediation of opioid-induced hyperalgesia by the melanocortin-1 receptor. Anesthesiology 2010;112:181-8
   PubMed Web of Science ®Google Scholar
• Kapas S, Cammas F, Hinson J, Agonist and receptor binding properties of adrenocorticotropin peptides using the cloned mouse adrenocorticotropin receptor expressed in a stably transfected HeLa cell line. Endocrinology 1996;137:3291-4
   PubMed Web of Science ®Google Scholar
• Hofmann K, Montibeller JA, Finn FM. ACTH antagonists. Proc Natl Acad Sci USA 1974;71:80-3
   PubMed Web of Science ®Google Scholar
• Kovalitskaya IA, Kolobov AA, Kampe-Nemm EA, Synthetic peptide KKRR corresponding to the human ACTH fragment 15-18 is an antagonist of the ACTH receptor. Russ J Bioorg Chem 2008;34:24-9
   Google Scholar
• Navolotskaya EV, Kovalitskaya YA, Sadovnikov VB, Synthetic ACTH-Like peptide GKVLKKRR, corresponding to the fragment 81-88 of human pro-interleukin-1 alpha, acts as an antagonist of ACTH receptor. Int J Pept Res Ther 2008;14:10-15
   Web of Science ®Google Scholar
• Butler AA, Kesterson RA, Khong K, A unique metabolic syndrome causes obesity in the melanocortin-3 receptor-deficient mouse. Endocrinology 2000;141(9):3518-21
   PubMed Web of Science ®Google Scholar
• Ellacott KLJ, Murphy JG, Marks DL, Obesity-induced inflammation in white adipose tissue is attenuated by loss of melanocortin-3 receptor signaling. Endocrinology 2007;148(12):6186-94
   PubMed Web of Science ®Google Scholar
• Sutton GM, Perez-Tilve D, Nogueiras R, The melanocortin-3 receptor is required for entrainment to meal intake. J Neurosci 2008;28(48):12946-55
   PubMed Web of Science ®Google Scholar
• Getting SJ, Di Filippo C, Christian HC. MC-3 receptor and the inflammatory mechanisms activated in acute myocardial infarct. J Leukoc Biol 2004;76:1-9
   PubMedGoogle Scholar
• Santoro N, Perrone L, Cirillo G, Effect of the melanocortin-3 receptor C17A and G241A variants on weight loss in childhood obesity. Am J Clin Nutr 2007;85(4):950-3
   PubMed Web of Science ®Google Scholar
• Marks DL, Hruby VJ, Brookhart G, The regulation of food intake by selective stimulation of the type 3 melanocortin receptor (MC3R). Peptides 2006;27:259-64
   PubMed Web of Science ®Google Scholar
• Ni X-P, Butler AA, Cone RD, Central receptors mediating the cardiovascular actions of melanocyte stimulating hormones J Hypertens 2006;24(11):2239-46
   PubMed Web of Science ®Google Scholar
• Li SJ, Varga K, Archer P, Melanocortin antagonists define two distinct pathways of cardiovascular control by alpha- and gamma-melanocyte-stimulating hormones. J Neurosci 1996;16:5182-8
   PubMed Web of Science ®Google Scholar
• King SH, Mayorov AV, Balse-Srinivasan P, Melanocortin receptors, melanotroic peptides and penile erection. Curr Topics Med Chem 2007;7:1111-19
   Web of Science ®Google Scholar
• Kavarana MJ, Trivedi D, Cai M, Novel cyclic templates of alpha-MSH give highly selective and potent antagonists/agonists for human melanocortin-3/4 receptors. J Med Chem 2002;45:2644-50
   PubMed Web of Science ®Google Scholar
• Mayorov AV, Cai M, Palmer ES, Structure-activity relationships of cyclic lactam analogues of alpha-melanocyte-stimulating hormone (alpha-MSH) targeting the human melanocortin-3 receptor. J Med Chem 2008;51:187-95
   PubMed Web of Science ®Google Scholar
• Ballet S, Mayorov AV, Cai M, Novel selective human melanocortin- 3 receptor ligands: use of the 4-amino-1,2,4,5-tetrahydro-2-benzazepin-3-one (Aba) scaffold. Bioorg Med Chem Lett 2007;17:2492-8
   PubMed Web of Science ®Google Scholar
• Mayorov AV, Cai M, Chandler KB, Development of cyclic gamma-MSH analogues with selective hMC3R agonist and hMC3R/hMC5R antagonist activities. J Med Chem 2006;49:1946-52
   PubMed Web of Science ®Google Scholar
• Grieco P, Cai M, Han G, Further structure-activity studies of lactam derivatives of MT-II and SHU-9119: their activity and selectivity at human melanocortin receptors 3, 4 and 5. Peptides 2007;28:1191-6
   PubMed Web of Science ®Google Scholar
• Grieco P, Lavecchia A, Cai M, Structure-activity studies of the melanocortin peptides: discovery of potent and selective affinity antagonists for the hMC3 and hMC4 receptors. J Med Chem 2002;45:5287-94
   PubMed Web of Science ®Google Scholar
• Cai M, Mayorov AV, Cabello C, Novel 3D pharmacophore of alpha-MSH/gamma-MSH hybrids leads to selective human MC1R and MC3R analogues. J Med Chem 2005;48:1839-48
   PubMed Web of Science ®Google Scholar
• Chen M, Cai M, Aprahamian CJ, Contribution of the conserved amino acids of the melanocortin-4 receptor in Nle4,D-Phe7]-alpha-melanocyte-stimulating hormone binding and signaling. J Biol Chem 2007;282:21712-19
   PubMed Web of Science ®Google Scholar
• Mountjoy K, Mortrud M, Low M, Localization of the melanocortin-4 receptor (MC4R) in neuroendocrine and autonomic control circuits in the brain. Mol Endocrinol 1994;8:1298-308
   PubMed Web of Science ®Google Scholar
• Starowicz K, Bilecki W, Sieja A, Melanocortin 4 receptor is expressed in the dorsal root ganglions and down-regulated in neuropathic rats. Neurosci Lett 2004;358:79-82
   PubMed Web of Science ®Google Scholar
• Tanabe K, Gamo K, Aoki S, Melanocortin receptor 4 is induced in nerve-injured motor and sensory neurons of mouse. J Neurochem 2007;101:1145-52
   PubMed Web of Science ®Google Scholar
• Fan W, Boston BA, Kesterson RA, Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature 1997;385:165-8
   PubMed Web of Science ®Google Scholar
• Cone RD. Studies of the physiological functions of the melanocortin system. Endocr Rev 2006;27:736-49
   PubMed Web of Science ®Google Scholar
• Jean-Christophe P, Hofbauer K. Monoclonal antibodies directed to the melanocortin-4 receptor ( MC4R ) and their use in the treatment of cachexia and related conditions. Can Pat Appl 2009
   Google Scholar
• Wessells H, Fuciarelli K, Hansen J, Synthetic melanotropic peptide initiates erections in men with psychogenic erectile dysfunction: double-blind, placebo controlled crossover study. J Urol 1998;160:389-93
   PubMed Web of Science ®Google Scholar
• Wessells H, Gralnek D, Dorr R, Effect of an alpha-melanocyte stimulating hormone analog on penile erection and sexual desire in men with organic erectile dysfunction. Urology 2000;56:641-6
   PubMed Web of Science ®Google Scholar
• Bednarek MA, MacNeil T, Kalyani RN, Selective, high affinity peptide antagonists of alpha-melanotropin action at human melanocortin receptor 4: their synthesis and biological evaluation in vitro. J Med Chem 2001;44:3665-72
   PubMed Web of Science ®Google Scholar
• Kask A, Mutulis F, Muceniece R, Discovery of a novel superpotent and selective melanocortin-4 receptor antagonist ( HS024 ): evaluation in vitro and in vivo. Endocrinology 1998;139:5006-14
   PubMed Web of Science ®Google Scholar
• Balse-Srinivasan P, Grieco P, Cai M, Structure-activity relationships of gamma-melanocortin MC3, MC4, and MC5 receptors. Discovery of highly selective hMC3R, hMC4R, and hMC5R analogues. J Med Chem 2003;46(23):4965-73
   PubMed Web of Science ®Google Scholar
• Schioth HB, Mutulis F, Muceniece R, Discovery of novel melanocortin4 receptor selective MSH analogues. Br J Pharmacol 1998;124:75-82
   PubMed Web of Science ®Google Scholar
• Skuladottir GV, Jonsson L, Skarhedinsson JO, Long term orexigenic effect of a novel melanocortin 4 receptor selective antagonist. Br J Pharmacol 1999;126:27-34
   PubMed Web of Science ®Google Scholar
• Grieco P, Lavecchia A, Cai M, Structure-activity studies of the melanocortin peptides: discovery of potent and selective affinity antagonists for the hMC3 and hMC4 receptors. J Med Chem 2002;45(24):5287-94
   PubMed Web of Science ®Google Scholar
• Chakia S, Ogawab S, Todaa Y, Involvement of the melanocortin MC4 receptor in stress-related behavior in rodents. Eur J Pharmacol 2003;474:95-101
   PubMed Web of Science ®Google Scholar
• Ying J, Gu X, Cai M, Design, synthesis, and biological evaluation of new cyclic melanotropin peptide analogues selective for the human melanocortin-4 receptor J Med Chem 2006;49(23):6888-96
   PubMed Web of Science ®Google Scholar
• Chaki S, Hirota S, Funakoshi T, Anxiolytic-like and antidepressant-like activities of MCL0129 (1-[(S)-2-(4-fluorophenyl)-2-(4-isopropylpiperadin-1-yl)ethyl]-4-[4-(2-methoxynaphthalen-1-yl)butyl]piperazine), a novel and potent nonpeptide antagonist of the melanocortin-4 receptor. J Pharmacol Exp Therap 2003;304 (2):818-26
   PubMed Web of Science ®Google Scholar
• Chaki S, Oshida Y, Ogawa S, MCL0042: a nonpeptidic MC4 receptor antagonist and serotonin reuptake inhibitor with anxiolytic- and antidepressant-like activity. Pharmacol Biochem Behav 2005;82(4):621-6
   PubMed Web of Science ®Google Scholar
• Jiang W, Tran JA, Tucci FC, Synthesis and characterization of pyrrolidine derivatives as potent agonists of the human melanocortin-4 receptor. Bioorg Med Chem Lett 2007;17(23):6546-52
   PubMed Web of Science ®Google Scholar
• Sharma S, Shi Y-Q, Wu Z, Bicyclic melanocortin-specific compounds. US 2004/0152134A1; 2004
   Google Scholar
• Pontillo J, Arellano M, Tran IA, Structure–activity relationship of a series of cyclohexylpiperidines bearing an amide side chain as antagonists of the human melanocortin-4 receptor. Bioorg Med Chem Lett 2005;15:3434-8
   PubMed Web of Science ®Google Scholar
• Vos TJ, Balani S, Blackburn V, Identification and structure-activity relationships of a new series of melanocortin-4 receptor antagonists. Bioorg Med Chem Lett 2006;16:2302-5
   PubMed Web of Science ®Google Scholar
• Nakazato A, Ishii T, Nozawa H. Use of piperazine derivatives as MC4 receptor antagonists and therapeutic agents containing them for treatment anxiety neurosis or depression. JP2005035983; 2005
   Google Scholar
• Pontillo J, Tran JA, Markison S, A potent and selective nonpeptide antagonist of the melanocortin-4 receptor induces food intake in satiated mice. Bioorg Med Chem Lett 2005;15:2541-6
   PubMed Web of Science ®Google Scholar
• Yang Y, Cai M, Chen M, Key amino acid residues in the melanocortin-4 receptor for nonpeptide THIQ specific binding and signaling. Regul Peptides 2009;155(1-3):46-54
   PubMed Web of Science ®Google Scholar
• Labbe O, Desarnaud F, Eggerickx D, Molecular cloning of a mouse melanocortin 5 receptor gene widely expressed in peripheral tissues. Biochemistry 1994;33(15):4543-9
   PubMed Web of Science ®Google Scholar
• Chen W, Kelly MA, Opitz-Araya X, Exocrine gland dysfunction in MC5 -R-deficient mice: evidence for coordinated regulation of exocrine gland function by melanocortin peptides. Cell 1997;91(6):789-98
   PubMed Web of Science ®Google Scholar
• Hiramoto K, Hashimoto M, Orita K, alpha-Melanocyte-Stimulating hormone plays an important role in the onset of pollinosis in a pollen allergy mouse model. Int Arch Allergy Immunol 2010;153(1):13-18
   PubMed Web of Science ®Google Scholar
• Blaskovich MAT, Cassidy PJ. Preparation of 1,4-diazepan-2-one peptidomimetics as MC5R melanocortin receptor modulators for treating conditions related to this receptor. U.S. Patent Appl Publ Chemical Indexing Equivalent to 151:313916 US. PCT Int Appl 2009:282
   Google Scholar
• Balse-Srinivasan PM, Grieco P, Cai M, Structure-activity relationships of novel cyclic alpha-MSH/beta-MSH hybrid analogues that lead to potent and selective ligands for the human MC3R and human MC5R. J Med Chem 2003;46:3728-33
   PubMed Web of Science ®Google Scholar
• Grieco P, Cai M, Liu L, Design and microwave assisted synthesis of novel macrocyclic peptides active at melanocortin receptors: discovery of potent and selective hMC5R receptor antagonists. J Med Chem 2008;51(9):2701-7
   PubMed Web of Science ®Google Scholar
• Cain JP, Mayorov AV, Cai M, Design, synthesis, and biological evaluation of a new class of small molecule peptide mimetics targeting the melanocortin receptors. Bioorg Med Chem Lett 2006;16(20):5462-7
   PubMed Web of Science ®Google Scholar